إعلان
إعلان

KALA

KALA logo

KALA BIO, Inc. Common Stock

0.62
USD
برعاية
-0.03
-4.47%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

0.61

-0.01
-0.81%

تقارير أرباح KALA

النسبة الإيجابية المفاجئة

KALA تفوق 15 من 34 آخر التقديرات.

44%

التقرير التالي

بيانات التقرير القادم
٣٠ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.89
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
+3.49%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
-48.85%

KALA BIO, Inc. Common Stock earnings per share and revenue

On ١٩ نوفمبر ٢٠٢٥, KALA reported earnings of -0.86 USD per share (EPS) for Q3 25, beating the estimate of -1.47 USD, resulting in a 41.67% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -8.10% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 المحللين forecast an EPS of -0.89 USD, with revenue projected to reach -- USD, implying an زيادة of 3.49% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, KALA BIO, Inc. Common Stock reported EPS of -$0.86, beating estimates by 41.67%, and revenue of $0.00, 0% as expectations.
The stock price moved down -8.1%, changed from $0.69 before the earnings release to $0.63 the day after.
The next earning report is scheduled for ٣٠ مارس ٢٠٢٦.
Based on 4 المحللين, KALA BIO, Inc. Common Stock is expected to report EPS of -$0.89 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان